A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma
Phase of Trial: Phase I/II
Latest Information Update: 08 Jul 2017
At a glance
- Drugs NY-ESO-1c259 TCR-transduced lymphocytes (Primary) ; Cyclophosphamide; Fludarabine
- Indications Liposarcoma
- Focus Therapeutic Use
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 05 Jun 2017 According to an Adaptimmune Therapeutics media release, as of May 18, 2017, 3 subjects have been enrolled in the study.
- 05 Jun 2017 According to an Adaptimmune Therapeutics media release, trial design has been presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2017.